SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-103241
Filing Date
2021-04-01
Accepted
2021-04-01 07:36:29
Documents
8
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d156620ddef14a.htm DEF 14A 415555
2 GRAPHIC g156620g30o29.jpg GRAPHIC 593365
3 GRAPHIC g156620g36u14.jpg GRAPHIC 36635
4 GRAPHIC g156620pc0001.jpg GRAPHIC 2030
5 GRAPHIC g156620pc0002.jpg GRAPHIC 947
6 GRAPHIC g156620pc0003.jpg GRAPHIC 864
7 GRAPHIC g156620pc0004.jpg GRAPHIC 1213
8 GRAPHIC g156620pc0005.jpg GRAPHIC 1001
  Complete submission text file 0001193125-21-103241.txt   1278183
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39335 | Film No.: 21796039
SIC: 2834 Pharmaceutical Preparations